EGG vs LAWR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Enigmatig Limited (EGG) exhibits a stable financial health profile with a Piotroski F-Score of 6/9 and an exceptionally clean balance sheet, yet it is fundamentally decoupled from its valuation. The stock trades at a massive premium ($6.31) compared to its Graham Number ($0.51) and Intrinsic Value ($0.14), supported by an unsustainable P/E of 315.50 and a Price/Sales ratio of 39.47. Most concerning is the severe revenue contraction of -40.30% YoY and a deeply negative operating margin of -45.66%, suggesting the core business is struggling despite positive net profit margins. With a technical trend of 0/100 and weak insider sentiment, there is no data-driven justification for the current price level.
LAWR presents a high-risk profile characterized by a mediocre Piotroski F-Score of 4/9 and a critical lack of fundamental stability. While the company maintains a decent current ratio, it is plagued by severe operational inefficiency with an operating margin of -255.76% and a negative Price-to-Book ratio of -38.53, indicating negative shareholders' equity. Revenue is contracting significantly (-28.20% YoY) in a sector where peers are growing, suggesting a loss of market competitiveness. The combination of negative equity and massive losses makes this a speculative play with poor deterministic health.
Compare Another Pair
Related Comparisons
EGG vs LAWR: Head-to-Head Comparison
This page compares Enigmatig Limited (EGG) and Robot Consulting Co., Ltd. (LAWR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.